Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : All Clowns Must Be Destroyed -- Ignore unavailable to you. Want to Upgrade?

To: patron_anejo_por_favor who wrote (33459)	5/17/2000 1:28:00 PM
From: Ilaine	Read Replies (1) \| Respond to of 42523

Ordinarily, I would agree with you, but in this case, you should recall that biotech, particularly the gene sequencing companies like Celera, tanked after Clinton and Blair jointly stated that patents should not be issued on naturally occurred genes, that is, genes which have not been genetically modified in any way. It so happens that what Clinton and Blair said is an accurate statement of the law as it is on the books, but Celera, nevertheless, is attempting to patent naturally occuring gene sequences, and some patents have been issued for naturally occuring substances. This is a very controversial subject, with an enormous international focus. Pitted against Celera is the entire community of research scientists at places like NIH and universities and non-profit foundations around the world. They argue, and I agree, that Celera can't patent the human genome, they can only patent modified genes, and novel uses for the genes. In fact, the European patent office just revoked a use patent granted on the neem plant, because it has been used as an antibacterial and fungicidal agent for centuries. The issue is very complex, and the original statement by Clinton was rather broad. So it was proper for him to try to clarify his original statement. I don't think he did a good job of that, but he's not a patent lawyer. I'm not either, but my husband has been a patent examiner for over ten years (not in biotech), and even he finds biotech patents confusing.